Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Gene expression profiles of laser-captured adjacent neuronal subtypes.
Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR, Erlander MG. Luo L, et al. Among authors: rogers ke. Nat Med. 1999 Jan;5(1):117-22. doi: 10.1038/4806. Nat Med. 1999. PMID: 9883850 No abstract available.
Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors.
Brown LM, Rogers KE, Aroonsakool N, McCammon JA, Insel PA. Brown LM, et al. Among authors: rogers ke. J Biol Chem. 2014 Oct 17;289(42):29148-57. doi: 10.1074/jbc.M114.569319. Epub 2014 Sep 2. J Biol Chem. 2014. PMID: 25183009 Free PMC article.
Cloning, localization, and functional expression of sodium channel beta1A subunits.
Kazen-Gillespie KA, Ragsdale DS, D'Andrea MR, Mattei LN, Rogers KE, Isom LL. Kazen-Gillespie KA, et al. Among authors: rogers ke. J Biol Chem. 2000 Jan 14;275(2):1079-88. doi: 10.1074/jbc.275.2.1079. J Biol Chem. 2000. PMID: 10625649
Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
Almeida B, Nag OK, Rogers KE, Delehanty JB. Almeida B, et al. Among authors: rogers ke. Molecules. 2020 Dec 1;25(23):5672. doi: 10.3390/molecules25235672. Molecules. 2020. PMID: 33271886 Free PMC article. Review.
Analytic solution of the SEIR epidemic model via asymptotic approximant.
Weinstein SJ, Holland MS, Rogers KE, Barlow NS. Weinstein SJ, et al. Among authors: rogers ke. Physica D. 2020 Oct;411:132633. doi: 10.1016/j.physd.2020.132633. Epub 2020 Jun 25. Physica D. 2020. PMID: 32834248 Free PMC article.
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.
Yadav R, Bergen PJ, Rogers KE, Kirkpatrick CMJ, Wallis SC, Huang Y, Bulitta JB, Paterson DL, Lipman J, Nation RL, Roberts JA, Landersdorfer CB. Yadav R, et al. Among authors: rogers ke. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01679-19. doi: 10.1128/AAC.01679-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31636062 Free PMC article.
Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
Rees VE, Yadav R, Rogers KE, Bulitta JB, Wirth V, Oliver A, Boyce JD, Peleg AY, Nation RL, Landersdorfer CB. Rees VE, et al. Among authors: rogers ke. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e01150-18. doi: 10.1128/AAC.01150-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30104278 Free PMC article.
Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.
Yadav R, Rogers KE, Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB. Yadav R, et al. Among authors: rogers ke. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e00078-18. doi: 10.1128/AAC.00078-18. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29463528 Free PMC article.
Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model.
Landersdorfer CB, Rees VE, Yadav R, Rogers KE, Kim TH, Bergen PJ, Cheah SE, Boyce JD, Peleg AY, Oliver A, Shin BS, Nation RL, Bulitta JB. Landersdorfer CB, et al. Among authors: rogers ke. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02055-17. doi: 10.1128/AAC.02055-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29437610 Free PMC article.
Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling.
Landersdorfer CB, Yadav R, Rogers KE, Kim TH, Shin BS, Boyce JD, Nation RL, Bulitta JB. Landersdorfer CB, et al. Among authors: rogers ke. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02053-17. doi: 10.1128/AAC.02053-17. Print 2018 Apr. Antimicrob Agents Chemother. 2018. PMID: 29339388 Free PMC article.
44 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback